利用纳米化TLR配体增强抗痢疾阿米巴疫苗的活性

Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica

点击次数:431   下载次数:274
中文摘要:本研究评估了纳米脂质体佐剂增强抗痢疾阿米巴 Gal/Ga1NAc血凝素LecA抗原粘膜免疫反应的能力。分别以包含TLR抗原的明矾、乳剂和脂质体对CBA/J小鼠进行免疫。结果表明:包含TLR抗原的纳米脂质体传递系统可用于抗肠道病原菌疫苗的制备,尤其适用于激发多种免疫反应的情况。
外文摘要:Diarrheal infectious diseases represent a major cause of global morbidity and mortality. There is an urgent need for vaccines against diarrheal pathogens, especially parasites. Modern subunit vaccines rely on combining a highly purified antigen with an adjuvant to increase their efficacy. In the present study, we evaluated the ability of a nanoliposome adjuvant system to trigger a strong mucosal immune response to the Entamoeba histolytica Gal/Ga1NAc lectin LecA antigen. CBA/J mice were immunized with alum, emulsion or liposome based formulations containing synthetic TLR agonists. A liposome formulation containing TLR4 and TLR7/8 agonists was selected based on its ability to generate intestinal IgA, plasma IgG2a/IgG1, IFN-gamma, and IL-17A. Immunization with a mucosal prime followed by a parenteral boost generated a high mucosal IgA response that inhibited adherence of parasites to mammalian cells. Inclusion of the immune potentiator all-trans retinoic acid in the regimen further improved the mucosal IgA response. Immunization protected from infection with up to 55% efficacy. Our results show that a nanoliposome delivery system containing TLR agonists is a promising prospect for the development of vaccines against enteric pathogens, especially when a multifaceted immune response is desired.
外文关键词: Liposome; Vaccine; Immune response; Amebiasis; Entamoeba
作者:Abhyankar, MM; Noor, Z; Tomai, MA; Elyecrog, J; Fox, CB; Petri, WA
作者单位:美国弗吉尼亚大学
期刊名称:VACCINE
期刊影响因子:3.413
出版年份:2017
出版刊次:2
点击下载:利用纳米化TLR配体增强抗痢疾阿米巴疫苗的活性
  1. 编译服务:动物支原体学
  2. 编译者:程金花
  3. 编译时间:2017-04-17